Valproic acid, but not lithium, alters telomere homeostasis and telomerase activity in a neuronal in vitro model
Background: Individuals with bipolar disorder are characterized by shorter telomere length (TL), a biomarker of cellular aging regulated by three multi-protein complexes (the Shelterin complex, telomerase holoenzyme, and CST complex) and accessory proteins. To date, the comprehensive effects of two commonly prescribed mood stabilizers, lithium (Li) and valproic acid (VPA), on the telomere homeostasis system as a whole have not been investigated at therapeutic concentrations. Aim: This study aimed to analyze the effects of Li (1 mM) and VPA (0.48 mM) in an in vitro neuronal model (SH-SY5Y) over 7, 14, and 21 (D21) days. Methods: We measured the expression of 18 genes encoding proteins involved in the telomere homeostasis system (RT-qPCR), protein levels of the telomerase catalytic subunit TERT (telomerase reverse transcriptase) (Western blot), telomerase activity (Telomere Repeat Amplification Protocol), and TL (qPCR). Results: Li showed no effect on telomere homeostasis. VPA affected the entire system at D21 by upregulating two out of six shelterin complex genes, downregulating four out of seven telomerase complex genes (including TERT ), oppositely regulating two CST complex genes, and downregulating accessory protein genes ( RTEL1 and APOLLO ). VPA also reduced TERT protein levels in nuclear extracts and telomerase activity at D21 without any change in TL. Conclusion: VPA, but not Li, affects telomere homeostasis in neuronal cells. SH-SY5Y cells are immortalized cells, thus limiting their direct relevance to primary neurons.
Authors
- Bruno Étain (ORCID: https://orcid.org/0000-0002-5377-1488)
- Xavier Declèves (ORCID: https://orcid.org/0000-0002-9526-2294)
- Cynthia Marie‐Claire (ORCID: https://orcid.org/0000-0002-2282-134X)
- Arthna Rathes
- Frank Bellivier
- Lou-Ann Marivin
- Alicja Puszkiel
- Johanna Thurin
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Fondation FondaMental (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Fernand-Widal (FR)
- Hôpital Lariboisière (FR)
- Optimisation Thérapeutique en Neuropsychopharmacologie (FR)
- Groupe Hospitalo-Universitaire Paris Nord (FR)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1177/02698811261504443
- Primary Topic
- Telomeres, Telomerase, and Senescence
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fondation FondaMental
- Fondation de France
- Centre National de la Recherche Scientifique